[1]童迪夷,丁东新.信息化管理对骨质疏松患者药物依从性及治疗效果的影响[J].医学信息,2021,34(05):133-135.[doi:10.3969/j.issn.1006-1959.2021.05.038]
　TONG Di-yi,DING Dong-xin.The Influence of Information Management on the Compliance of Patients with Osteoporosis and Treatment Effect[J].Medical Information,2021,34(05):133-135.[doi:10.3969/j.issn.1006-1959.2021.05.038]
点击复制

信息化管理对骨质疏松患者药物依从性及治疗效果的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年05期
页码:
133-135
栏目:
临床研究
出版日期:
2021-03-01

文章信息/Info

Title:
The Influence of Information Management on the Compliance of Patients with Osteoporosis and Treatment Effect
文章编号:
1006-1959（2021）05-0133-03
作者:
童迪夷; 丁东新
（同济大学附属杨浦医院老年一科，上海 200090）
Author(s):
TONG Di-yi; DING Dong-xin
(The First Department of Geriatrics,Yangpu Hospital,Tongji University,Shanghai 200090,China)
关键词:
信息化管理; 骨质疏松; 药物持有率
Keywords:
Information management; Osteoporosis; Drug holding rate
分类号:
R681
DOI:
10.3969/j.issn.1006-1959.2021.05.038
文献标志码:
A
摘要:
目的 了解信息化管理对骨质疏松患者药物依从性及治疗效果的影响。方法 选取2017年1月~2018年12月上海同济大学附属杨浦医院收治的骨质疏松患者72例，采取信息化管理方式提示患者按时服药及定期随访，比较患者干预前、干预后6、12个月药物持有率（MPR）及股骨颈骨密度T值。结果 干预后6、12个月MPR高于干预前，差异有统计学意义（P＜0.05）；干预后12个月股骨颈骨密度T值低于干预前，差异有统计学意义（P＜0.05）；但干预后6个月股骨颈骨密度T值与干预前比较，差异无统计学意义（P＞0.05）。不同年龄及性别间MPR及股骨颈骨密度T值比较，差异无统计学意义（P＞0.05）。结论 通过信息化管理方式对骨质疏松患者进行督导1年后，患者依从性明显改善且有较好的治疗效果，各年龄段及性别无明显差异，进一步说明老年患者对信息化管理有较好的接受度。
Abstract:
Objective To understand the impact of information management on the compliance of patients with osteoporosis and treatment effects.Methods A total of 72 patients with osteoporosis who were admitted to the Yangpu Hospital of Tongji University in Shanghai from January 2017 to December 2018 were selected.Information-based management methods were adopted to remind patients to take medication on time and regular follow-ups, and to analyze the drug holding rate (MPR) and femoral neck bone mineral density T value of patients before intervention, 6 and 12 months after intervention.Results The MPR at 6 and 12 months after the intervention was higher than before the intervention, the difference was statistically significant (P<0.05);The T value of femoral neck bone mineral density at 12 months after the intervention was lower than before the intervention, the difference was statistically significant (P<0.05);However, there was no significant difference in the T value of femoral neck bone mineral density at 6 months after the intervention and before the intervention (P>0.05).There was no statistically significant difference in MPR and femoral neck bone mineral density T values between different ages and genders (P>0.05).Conclusion After 1 year of monitoring osteoporosis patients through information management, the patient’s compliance has been significantly improved and the treatment effect has been better.There is no significant difference between age groups and genders, which further shows that elderly patients have a better acceptance of information management.

参考文献/References:

[1]王冰梅,赵娜,于洪宇,等.骨质疏松的中西医研究进展[J].中医药信息,2016,33(6):128-131. [2]谢雁鸣,宇文亚,董福慧,等.原发性骨质疏松症中医临床实践指南(摘录)[J].中华中医药杂志,2012,27(7):1886-1890. [3]游利骨质疏松症的现状、筛查和预防[J].中国全科医学,2016,19(14):1616-1619. [4]Adler RA,El-Hajj Fuleihan G,Bauer DC,et al.Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment:Report of a Task Force of the American Society for Bone and Mineral Research[J].Journal of Bone and Mineral Research,2016,31(1):16-35. [5]林树峰,李毅中.骨质疏松药物治疗率和依从性[J].中国骨质疏松杂志,2020(3):439-444. [6]Long Z,Wu J,Xiang W,et al.Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy[J].Med Sci Monit,2020(26):e924699. [7]Barcenilla-Wong AL,Cross M,Fry M, et al.Ambiguity hindering self-management and prevention of osteoporosis in post-menopausal women[J].Arch Osteoporos,2020,15(1):73. [8]陈盈婷.骨质疏松症患者应用双膦酸盐类药物治疗的持续性和依从性调查[D].北京中医药大学,2016. [9]Fitzpatrick LA,Badamgarav E.A new look at osteoporosis outcomes: the influence of treatment，compliance，persistence，and adherence[J].Mayo Clin Proc,2006,81(8):1009-1012. [10]Huybrdchts KF,Ishak KJ,Caro JJ.Assessment of compliance with osteoporosis treatment and its consequences in a managed care population[J].Bone,2006(38):922-928. [11]Rabenda V,Mertens R,Fabri V,et al.Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic[J].Osteoporos Int,2008,19(6):811-818. [12]许昊,王培文,李毅中,等.骨密度检测对脆性髋部骨折患者骨质疏松诊疗率的影响[J].中华老年医学杂志,2017,36(7):784-787. [13]罗展鹏,马远征,王亮,等.基于数字化平台的持续化骨质疏松健康管理对生活习惯,药物依从性的长期影响[J].中国骨质疏松杂志,2017,3(23):62-66. [14]金宇翔.院内药物自我管理训练对改善患者出院后服药依从性的意义[J].中医药管理杂志,2019,27(15):232-233. [15]Kanis JA,Cooper C,Rizzoli R,et al.European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Osteoporos Int,2019,30(1):3-44.

相似文献/References:

[1]吴玲,李玉兰.个性化心理护理干预应用于骨质疏松的临床效果观察[J].医学信息,2018,31(01):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
　WU Ling,LI Yu-lan.The Clinical Effect of Personalized Psychological Nursing Intervention on Osteoporosis[J].Medical Information,2018,31(05):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
[2]王 忻,赵 毅,朱 悦,等.甲状旁腺激素应用于大鼠脊髓损伤后防治骨质疏松的效果分析[J].医学信息,2018,31(02):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
　WANG Xin,ZHAO Yi,ZHU Yue,et al.Effect of Parathyroid Hormone on Prevention and Treatment of Osteoporosis after Spinal Cord Injury in Rats[J].Medical Information,2018,31(05):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
[3]刘小花.经皮穿刺椎体成形术治疗老年性骨质疏松性 椎体压缩骨折的疗效分析[J].医学信息,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
　LIU Xiao-hua.The Effect of Percutaneous Vertebroplasty in the Treatment of Senile Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
[4]杨可佳,孙春华,洪全明,等.经皮椎体成形术治疗骨质疏松性压缩性椎体骨折的疗效观察[J].医学信息,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
　YANG Ke-jia,SUN Chun-hua,HONG Quan-ming,et al.Therapeutic Effect of Percutaneous Vertebroplasty for treatment of Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(05):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
[5]蒋俊良.老年股骨转子间骨折的手术治疗方法[J].医学信息,2018,31(23):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
　JIANG Jun-liang.Research Progress of Intertrochanteric Fractures of Femurin the Elderly[J].Medical Information,2018,31(05):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
[6]张 强,杨 帆,陈 康,等.椎体成形术中明胶海绵填塞治疗椎体前壁破损的 OVCFs的临床疗效观察[J].医学信息,2019,32(11):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
　ZHANG Qiang,YANG Fan,CHEN Kang,et al.Clinical Observation of OVCFs in the Treatment of Anterior Wall Fracture of Vertebral Body with Gelatin Sponge During Vertebroplasty[J].Medical Information,2019,32(05):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
[7]庞 渊,张 庆,阿伍提·艾克木,等.经皮椎体成形术治疗骨质疏松性椎体压缩性骨折的 疗效分析[J].医学信息,2019,32(11):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
　PANG Yuan,ZHANG Qing,Awti Aikemu,et al.Therapeutic Effect of Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Medical Information,2019,32(05):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
[8]罗巧彦,凌止发,严宗逊,等.中老年女性骨代谢指标与骨质疏松的相关性研究[J].医学信息,2019,32(17):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
　LUO Qiao-yan,LING Zhi-fa,YAN Zong-xun,et al.Correlation between Bone Metabolic Markers and Osteoporosis in Middle-aged and Elderly Women[J].Medical Information,2019,32(05):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
[9]熊义博,刘学员,邓泽熙,等.老年人骨质疏松与动脉硬化的关系[J].医学信息,2019,32(19):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
　XIONG Yi-bo,LIU Xue-yuan,DENG Ze-xi,et al.Relationship Between Osteoporosis and Arteriosclerosis in the Elderly[J].Medical Information,2019,32(05):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
[10]聂雅娟,卢宇蓝,王慧君,等.基于网络平台的实验室管理系统设计与应用[J].医学信息,2019,32(13):16.[doi:10.3969/j.issn.1006-1959.2019.13.006]
　NIE Ya-juan,LU Yu-lan,WANG Hui-jun,et al.Design and Application of Laboratory Management System Based on Network Platform[J].Medical Information,2019,32(05):16.[doi:10.3969/j.issn.1006-1959.2019.13.006]

更新日期/Last Update: 1900-01-01